Showing results (1-10 of 1,882) with videos related to
Sort By:
Pageof 189
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Thromboxane biosynthesis and antagonism in humansG A FitzGerald, D J Fitzgerald, J A Lawson, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertensionF Catella, J A Lawson, D J Fitzgerald, et al.The Journal of Biological Chemistry|April 25, 1990
The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systemsK Takahara, R Murray, G A FitzGerald, et al.Lancet (London, England)|March 31, 1990
Thromboxane A2 synthesis in pregnancy-induced hypertensionD J Fitzgerald, W Rocki, R Murray, et al.British Journal of Clinical Pharmacology|July 1, 1996
8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivoN Delanty, M Reilly, D Pratico, et al.Trends in Cardiovascular Medicine|January 18, 2011
Antiplatelet and anticoagulant therapy during coronary thrombolysisD J Fitzgerald, G A FitzgeraldProceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activatorD J Fitzgerald, G A FitzgeraldThe Journal of Clinical Investigation|November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosisD J Fitzgerald, J Fragetta, G A FitzGeraldBlood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J FitzgeraldCirculation Research|July 1, 1989
Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivoD J Fitzgerald, F Wright, G A FitzGeraldPageof 189